<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213524</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA014002</org_study_id>
    <nct_id>NCT01213524</nct_id>
  </id_info>
  <brief_title>Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia</brief_title>
  <official_title>Biological and Behavioral Mechanisms of Smoking in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate the relative contributions of nicotine&#xD;
      replacement and sensorimotor replacement (i.e., smoking denicotinized cigarettes) on&#xD;
      abstinence-induced smoking urges, withdrawal-related negative affect, psychiatric symptoms,&#xD;
      cognitive task performance and 90-min ad libitum usual-brand smoking behavior in smokers with&#xD;
      schizophrenia and non-psychiatric smokers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study used a mixed between- and within-subjects design to investigate the separate and&#xD;
      combined effects of sensorimotor replacement for smoking (very low nicotine content [VLNC]&#xD;
      cigarettes vs. no cigarettes) and transdermal nicotine replacement (42 mg nicotine [NIC] vs.&#xD;
      placebo [PLA] patches) in smokers with schizophrenia and control smokers without psychiatric&#xD;
      illness. Each session contained a 5-h controlled administration period in which participants&#xD;
      underwent the following conditions, in counterbalanced order: VLNC + NIC, VLNC + PLA, no&#xD;
      cigarettes + NIC, no cigarettes + PLA, Usual Brand cigarettes + no patches. Next,&#xD;
      participants completed measures of cigarette craving, nicotine withdrawal, smoking habit&#xD;
      withdrawal, cigarette subjective effects, psychiatric symptoms and cognitive task performance&#xD;
      followed by a 90-min period of ad libitum usual-brand smoking.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Within-subjects design study that investigated the separate and combined effects of sensorimotor replacement for smoking (very low nicotine content [VLNC] cigarettes vs. no cigarettes) and transdermal nicotine replacement (42 mg nicotine [NIC] vs. placebo [PLA] patches). Participants were smokers with schizophrenia and equally-heavy smokers without psychiatric disorders. Each participant underwent the following conditions, in counterbalanced order: VLNC + NIC, VLNC + PLA, no cigarettes + NIC, no cigarettes + PLA, usual-brand cigarettes + no patches.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants and outcomes assessor were blind to patch condition (NIC or PLA)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Preferred Brand Smoke Intake (CO)</measure>
    <time_frame>90 min</time_frame>
    <description>preferred brand smoke intake (breath CO) after 5-hr &quot;satiation&quot; periods in which nicotine replacement and sensorimotor replacement were provided under double-blind conditions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on Smoking Urges - Brief Scale (QSU-Brief)</measure>
    <time_frame>5 hr</time_frame>
    <description>Measure of cigarette craving in which 10 items were rated on 100-mm visual analogue scales (0 = &quot;no urge at all&quot;, 100 = &quot;strongest urge you've ever had&quot;)</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Active nicotine replacement (NRT) + denicotinized cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 mg nicotine replacement plus sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>inactive transdermal patches plus sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active NRT + no cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 mg nicotine replacement with no sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo NRT + No cigarettes</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Double placebo: No nicotine or sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual brand smoking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>positive control: usual brand smoking</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>sensorimotor replacement</intervention_name>
    <description>denicotinized cigarettes</description>
    <arm_group_label>Active nicotine replacement (NRT) + denicotinized cigarettes</arm_group_label>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>42 mg transdermal nicotine replacement</intervention_name>
    <description>2 21-mg nicotine patches</description>
    <arm_group_label>Active NRT + no cigarettes</arm_group_label>
    <arm_group_label>Active nicotine replacement (NRT) + denicotinized cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo transdermal nicotine</intervention_name>
    <description>2 placebo patches matched to 21-mg nicotine patches</description>
    <arm_group_label>Placebo NRT + No cigarettes</arm_group_label>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual brand smoking</intervention_name>
    <description>participant smokes usual brand of cigarette</description>
    <arm_group_label>usual brand smoking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  schizophrenia or no psychiatric illness&#xD;
&#xD;
          -  18 and older&#xD;
&#xD;
          -  men and women&#xD;
&#xD;
          -  cigarette smokers, 20-50 cigarettes per day&#xD;
&#xD;
          -  would like to quit someday&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  medical conditions excluding transdermal nicotine replacement&#xD;
&#xD;
          -  pregnancy or lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Tidey, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brown University, 121 South Main Street</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>October 1, 2010</study_first_submitted>
  <study_first_submitted_qc>October 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2010</study_first_posted>
  <results_first_submitted>November 19, 2012</results_first_submitted>
  <results_first_submitted_qc>August 20, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2020</results_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Jennifer Tidey</investigator_full_name>
    <investigator_title>Associate Professor (Research)</investigator_title>
  </responsible_party>
  <keyword>nicotine</keyword>
  <keyword>craving</keyword>
  <keyword>dual-diagnosis</keyword>
  <keyword>comorbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the community using newspaper and other community advertisements.</recruitment_details>
      <pre_assignment_details>Participants underwent telephone and in-person screening for eligibility.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>VLNC + NIC</title>
          <description>Within-subjects study with 5 conditions that participants underwent in counter-balanced order:&#xD;
Transdermal nicotine replacement + sensorimotor replacement (denicotinized cigarettes)&#xD;
Transdermal nicotine replacement + no sensorimotor replacement&#xD;
Placebo patches + sensorimotor replacement&#xD;
Placebo patches + no sensorimotor replacement&#xD;
Usual brand cigarettes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75">Total number who signed informed consent.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68">Number of participants who continued in the study past baseline</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>high breath alcohol levels</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Session 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="63">Number who continued in the study to the next session</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Session 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59">Number who continued in study to next session</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Session 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56">Number who continued in the study to the next session</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Session 5</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56">Number who continued in the study to the next session</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Session 6</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56">Number who continued in the study to the next session</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Session 7</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Smokers With Schizophrenia</title>
        </group>
        <group group_id="B2">
          <title>Non-Psychiatric Controls</title>
          <description>Smokers without current psychiatric illness</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.4" spread="8.2"/>
                    <measurement group_id="B2" value="41.7" spread="11.7"/>
                    <measurement group_id="B3" value="43.6" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Preferred Brand Smoke Intake (CO)</title>
        <description>preferred brand smoke intake (breath CO) after 5-hr &quot;satiation&quot; periods in which nicotine replacement and sensorimotor replacement were provided under double-blind conditions</description>
        <time_frame>90 min</time_frame>
        <population>Participants who completed all conditions and for whom data are available</population>
        <group_list>
          <group group_id="O1">
            <title>Very Low Nicotine Content Cigarettes + Nicotine Replacement</title>
            <description>5-hr very low nicotine cigarettes + 42 mg nicotine replacement</description>
          </group>
          <group group_id="O2">
            <title>Very Low Nicotine Content Cigarettes + Placebo</title>
            <description>5-hr very low nicotine cigarettes + placebo patches</description>
          </group>
          <group group_id="O3">
            <title>No Cigarettes + Nicotine Replacement</title>
            <description>5-hr 42 mg nicotine replacement only</description>
          </group>
          <group group_id="O4">
            <title>No Cigarettes + Placebo</title>
            <description>5-hr placebo patches only</description>
          </group>
          <group group_id="O5">
            <title>Usual Brand Cigarettes</title>
            <description>5-hr use of usual-brand cigarettes</description>
          </group>
        </group_list>
        <measure>
          <title>Preferred Brand Smoke Intake (CO)</title>
          <description>preferred brand smoke intake (breath CO) after 5-hr &quot;satiation&quot; periods in which nicotine replacement and sensorimotor replacement were provided under double-blind conditions</description>
          <population>Participants who completed all conditions and for whom data are available</population>
          <units>ppm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="56"/>
                <count group_id="O4" value="56"/>
                <count group_id="O5" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.30" spread="8.31"/>
                    <measurement group_id="O2" value="3.16" spread="10.10"/>
                    <measurement group_id="O3" value="9.07" spread="6.95"/>
                    <measurement group_id="O4" value="10.54" spread="7.31"/>
                    <measurement group_id="O5" value="5.12" spread="10.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Questionnaire on Smoking Urges - Brief Scale (QSU-Brief)</title>
        <description>Measure of cigarette craving in which 10 items were rated on 100-mm visual analogue scales (0 = &quot;no urge at all&quot;, 100 = &quot;strongest urge you've ever had&quot;)</description>
        <time_frame>5 hr</time_frame>
        <population>Participants who completed the study and for whom data were available</population>
        <group_list>
          <group group_id="O1">
            <title>Very Low Nicotine Content Cigarettes + Nicotine Replacement</title>
            <description>5-hr very low nicotine cigarettes + 42 mg nicotine replacement</description>
          </group>
          <group group_id="O2">
            <title>Very Low Nicotine Content Cigarettes + Placebo</title>
            <description>5-hr very low nicotine cigarettes plus placebo patches</description>
          </group>
          <group group_id="O3">
            <title>No Cigarettes + Nicotine Replacement</title>
            <description>5-hr 42 mg nicotine replacement only</description>
          </group>
          <group group_id="O4">
            <title>No Cigarettes + Placebo</title>
            <description>5-hr placebo patches only</description>
          </group>
          <group group_id="O5">
            <title>Usual Brand Cigarettes</title>
            <description>5-hr use of usual brand cigarettes</description>
          </group>
        </group_list>
        <measure>
          <title>Questionnaire on Smoking Urges - Brief Scale (QSU-Brief)</title>
          <description>Measure of cigarette craving in which 10 items were rated on 100-mm visual analogue scales (0 = &quot;no urge at all&quot;, 100 = &quot;strongest urge you've ever had&quot;)</description>
          <population>Participants who completed the study and for whom data were available</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
                <count group_id="O3" value="52"/>
                <count group_id="O4" value="52"/>
                <count group_id="O5" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.02" spread="32.74"/>
                    <measurement group_id="O2" value="37.92" spread="34.94"/>
                    <measurement group_id="O3" value="67.08" spread="30.33"/>
                    <measurement group_id="O4" value="74.13" spread="26.47"/>
                    <measurement group_id="O5" value="24.48" spread="26.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Smokers With Schizophrenia</title>
        </group>
        <group group_id="E2">
          <title>Non-Psychiatric Controls</title>
          <description>Smokers without current psychiatric illness</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>headache</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>alcohol detoxification</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>suicidality</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>fall requiring stitches</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>car accident</sub_title>
                <description>self-report, not related</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jennifer Tidey, Ph.D.</name_or_title>
      <organization>Brown University</organization>
      <phone>401-863-6418</phone>
      <email>Jennifer_Tidey@brown.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

